These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8266951)

  • 1. Comments on study of antineoplastic drug handlers.
    Solimando DA; Edwards MS; Liter ME
    Am J Hosp Pharm; 1993 Nov; 50(11):2311-3. PubMed ID: 8266951
    [No Abstract]   [Full Text] [Related]  

  • 2. Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals.
    Crul M; Hilhorst S; Breukels O; Bouman-d'Onofrio JRC; Stubbs P; van Rooij JG
    J Occup Environ Hyg; 2020; 17(7-8):343-352. PubMed ID: 32633703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous training program for technicians handling antineoplastic drugs and occupational exposure risk].
    Dussart C; Favier B; Gilles L; Camal I; Almeras D; Latour JF; Grelaud G
    Bull Cancer; 2008 Sep; 95(9):821-2. PubMed ID: 18829414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Certification program in antineoplastic drug preparation for pharmacy technicians and pharmacists.
    Peters BG; Wilson AL; Lunik MC; Cataldo BK
    Am J Hosp Pharm; 1994 Aug; 51(15):1902-6. PubMed ID: 7942925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.
    Sugiura S; Asano M; Kinoshita K; Tanimura M; Nabeshima T
    J Oncol Pharm Pract; 2011 Mar; 17(1):14-9. PubMed ID: 20179165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of antineoplastic agents in pharmacy personnel. Part II: study of work-related risk factors.
    Schreiber C; Radon K; Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):11-6. PubMed ID: 12592577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of using technicians and not pharmacists to handle antineoplastic drugs.
    Welch CW; Deffenbaugh JH
    Am J Health Syst Pharm; 2000 Oct; 57(19):1750, 1753. PubMed ID: 11030026
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on long-term, not short-term, effects of antineoplastic drug handling are needed.
    Slimowitz R; Mitrik LJ
    Am J Hosp Pharm; 1993 Sep; 50(9):1862-3. PubMed ID: 8135230
    [No Abstract]   [Full Text] [Related]  

  • 10. Exposure of pharmacy technicians to antineoplastic agents: reevaluation after additional protective measures.
    Sessink PJ; Wittenhorst BC; Anzion RB; Bos RP
    Arch Environ Health; 1997; 52(3):240-4. PubMed ID: 9169636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of hospital pharmacists and nurses to antineoplastic agents.
    McDevitt JJ; Lees PS; McDiarmid MA
    J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statement of functions of pharmacists and non-professional personnel in hospital pharmacy. Approved by the Canadian Society of Hospital Pharmacists May, 1976.
    Can J Hosp Pharm; 1976; 29(5):161. PubMed ID: 1030378
    [No Abstract]   [Full Text] [Related]  

  • 15. [How hazardous are cytostatic agents to personnel?].
    Johansson H
    Vardfacket; 1979 Jan; 3(1):10-6. PubMed ID: 253513
    [No Abstract]   [Full Text] [Related]  

  • 16. Job satisfaction among hospital pharmacy personnel.
    Noel MW; Hammel RJ; Bootman JL
    Am J Hosp Pharm; 1982 Apr; 39(4):600-6. PubMed ID: 7081235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal status and functions of hospital-based pharmacy technicians and their relationship to clinical pharmacy services.
    Raehl CL; Pitterle ME; Bond CA
    Am J Hosp Pharm; 1992 Sep; 49(9):2179-87. PubMed ID: 1524058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Errors remaining in unit dose carts after checking by pharmacists versus pharmacy technicians.
    Becker MD; Johnson MH; Longe RL
    Am J Hosp Pharm; 1978 Apr; 35(4):432-4. PubMed ID: 645716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Work practices and policies of hospital pharmacists preparing antineoplastic agents.
    Christensen CJ; Lemasters GK; Wakeman MJ
    J Occup Med; 1990 Jun; 32(6):508-12. PubMed ID: 2380800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of Ohio hospital pharmacists toward pharmacy technicians.
    Govern VL; Birdwell SW; Sherrin TP
    Am J Hosp Pharm; 1991 Jun; 48(6):1228-33. PubMed ID: 1858801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.